The Sirtuin Mirage

For three decades, the longevity field has been captivated by the ‘sirtuin-mTOR-AMPK’ triumvirate. We’ve built an entire pharmacological industry on the assumption that caloric restriction (CR) works by activating metabolic sensors that reprogram the epigenome. However, as noted in recent critiques, the genetic necessity of these pathways for CR’s benefits remains largely unproven in loss-of-function models. I’m proposing a shift in perspective: CR doesn’t work by 'activating' a longevity program, but rather by stabilizing the JNK-AP-1 'off-state'. This prevents the metabolic noise of surplus energy from being transduced into chronic inflammation.

The Hypothesis: JNK as the Metabolic-to-Inflammatory Gatekeeper

I hypothesize that the primary mechanism of CR-mediated lifespan extension is simply an elevation of the activation threshold for the c-Jun N-terminal kinase (JNK) pathway. In a state of energy surplus, transient metabolic stressors—reactive oxygen species (ROS), endoplasmic reticulum (ER) stress, and high amino acid flux—act as signal noise. This noise keeps the JNK-AP-1 axis in a chronically primed, sub-threshold active state. This chronic priming is what drives the low-level transcription of pro-inflammatory factors like SASP, COX-2, and iNOS—a process we call inflammaging.

CR acts as a low-pass filter. By reducing methionine intake and lowering core body temperature, CR slows the kinetic rate of kinase cascades and damps the basal metabolic noise that would otherwise trip the JNK-AP-1 threshold. In this model, sirtuins and AMPK are secondary responses. They are downstream actors that might correlate with health, but they don't drive the fundamental suppression of inflammatory transcription.

Mechanistic Logic and Evidence

1. Rapid Suppression of Transcription: The fact that (short-term 10-day CR can attenuate inflammatory signaling processes in aged kidney tissue)[https://pubmed.ncbi.nlm.nih.gov/19199090/] suggests a kinetic inhibition of existing stress pathways rather than a slow remodeling of metabolic machinery. This rapid action is consistent with a reduction in phosphorylation flux through the JNK-AP-1 axis.
2. Upstream Dominance: (JNK signaling is implicated in insulin-regulated metabolic homeostasis and lifespan)[https://pmc.ncbi.nlm.nih.gov/articles/PMC3227503/], positioning it as the gatekeeper for insulin sensitivity. If JNK is suppressed, the canonical CR pathways—like improved insulin signaling—follow as a consequence, not a cause.
3. The Methionine-JNK Connection: Methionine restriction, a known CR mimetic, reduces ER stress. Since ER stress is a primary activator of the JNK-dependent inflammatory response, the benefits of methionine restriction may be entirely mediated by lowering the metabolic noise that triggers the JNK gate.

Proposed Falsification Study

To test this, we have to move beyond correlation. If the JNK-AP-1 axis is the primary gate, then CR should fail to extend lifespan in a model where JNK is constitutively active in a tissue-specific manner (the liver or hypothalamus, for example), even if sirtuins and AMPK are fully activated by the calorie deficit.

Furthermore, we should see that (10-day caloric restriction in aged rats inhibited upstream signaling cascades and DNA binding activity of both NF-κB and AP-1)[https://pubmed.ncbi.nlm.nih.gov/19199090/] regardless of the animal's sirtuin status. If SIRT1-knockout mice still show reduced AP-1 DNA-binding activity and suppressed COX-2 expression under CR, the sirtuin-centric model is officially dead. CR isn't a signal; it’s just the removal of the noise that causes us to age.